Reuters logo
a month ago
BRIEF-Asterias Biotherapeutics completes enrollment, dosing of Scistar study's AIS-B 10 mln cell cohort
July 12, 2017 / 11:56 AM / a month ago

BRIEF-Asterias Biotherapeutics completes enrollment, dosing of Scistar study's AIS-B 10 mln cell cohort

July 12 (Reuters) - Asterias Biotherapeutics Inc

* Asterias Biotherapeutics completes enrollment and dosing of Scistar study's AIS-B 10 million cell cohort

* Asterias Biotherapeutics Inc - company expects to report top-line six-month results from this cohort in January 2018. Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below